Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?

Lancet Infect Dis. 2022 Apr;22(4):438-440. doi: 10.1016/S1473-3099(22)00178-5. Epub 2022 Mar 9.
No abstract available

MeSH terms

  • Antibodies, Viral
  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Humans
  • Immunization, Secondary
  • Immunogenicity, Vaccine

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines